Rebeca Alba-Rubio

Rebeca Alba-Rubio

UNVERIFIED PROFILE

Are you Rebeca Alba-Rubio?   Register this Author

Register author
Rebeca Alba-Rubio

Rebeca Alba-Rubio

Publications by authors named "Rebeca Alba-Rubio"

Are you Rebeca Alba-Rubio?   Register this Author

10Publications

382Reads

34Profile Views

Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.

EBioMedicine 2019 Sep 16;47:156-162. Epub 2019 Aug 16.

Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.08.002DOI Listing
September 2019

Pappalysin-1 T cell receptor transgenic allo-restricted T cells kill Ewing sarcoma and .

Oncoimmunology 2017 17;6(2):e1273301. Epub 2017 Jan 17.

Laboratory for Functional Genomics and Transplantation Biology, Department of Pediatrics and Children's Cancer Research Center, Klinikum rechts der Isar, Technische Universität München , München, Germany.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2016.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2016.1273301DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353903PMC
January 2017

Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.

Oncotarget 2016 Jul;7(28):43267-43280

Laboratory for Functional Genomics and Transplantation Biology, Department of Pediatrics and Children's Cancer Research Center, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190022PMC
July 2016

Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Oncoimmunology 2016 Jun 25;5(6):e1175795. Epub 2016 Apr 25.

Children's Cancer Research Center and Department of Pediatrics, Klinikum rechts der Isar, Technische Universität München, Munich, Germany and Comprehensive Cancer Center Munich (CCCM) , Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1175795DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938321PMC
June 2016